Skip to main content

Advertisement

Table 1 Baseline characteristics of the 184 patients

From: Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study

Median (IQR) age at entry 38.5 (29–50) years
Male: female (n) 99: 85
Median (IQR) duration of UC before entry 33 (22–45) months
Extent of UC (n)
 Proctosigmoiditis 35 (19%)
 Left-sided colitis 119 (65%)
 Extensive colitisa 30 (16%)
Extraintestinal manifestations (n)
 Arthritis 8 (4%)
 Erythema nodosum/pyoderma gangrenosum 2 (1%)
Induction therapy for the current exacerbation (n)
 Mesalazine (Pentasa 4 g/day) 174 (95%)
 Corticosteroids (Prednisolone 30–60 mg/day) 149 (81%)
 Thiopurines (Azathioprine 50–100 mg/day) 39 (21%)
 Calcineurin inhibitors 0
 Biologics 0
Mayo endoscopic subscore (MES) at entry
 MES 2 158 (86%)
 MES 3 26 (14%)
  1. IQR interquartile rage, UC ulcerative colitis
  2. aInvolvement extends proximal to the splenic flexure